Ibogaine Related Fatalities: Compilation of Public Domain Case Reports 1990–2010
AI-extracted · unverified · confirm at source
Compilation of 12 ibogaine/iboga-related fatalities (1990–2010) from public domain sources; pre-existing cardiac disease, polysubstance use, and absent medical screening identified as recurring risk factors
Dosing: 4.5–29 mg/kg oral (HCl); 500mg–6g (extract/root bark); dose unknown in several cases (oral)
Contraindications: Pre-existing cardiac disease (prior MI, congenital defects, vascular disease), Hepatitis C or hepatic impairment, Concurrent methadone use without adequate taper, Concurrent benzodiazepine or opioid use during treatment, Absence of pre-treatment medical screening (ECG, liver function), Unsupervised or solo treatment settings, History of cardiac surgery or congenital heart defects